Saudi Aramco Extends GES Contract with Jacobs Engineering (JEC)
- Wall Street rises, buoyed by economic data; Dow sets high
- Twitter (TWTR) 'Takeover Money' Moves On as 'Trump Money' Moves In
- Amazon (AMZN) Could Open Over 2,000 Brick-and Mortar Groceries if Tests Succeed - DJ; Kroger (KR) on Watch
- Buy Any Seasonal Market Weakness Ahead of Year End Rally - Oppenheimer (SPY)
- After-Hours Stock Movers 12/05: (TXMD) (COUP) (BOBE) Higher; (SB) (LXRX) (STWD) Lower (more...)
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Jacobs Engineering Group Inc. (NYSE: JEC) announced it received an amendment from Saudi Aramco for its general engineering services (GES) contract.
While officials did not disclose the contract value, the five-year extension builds on the framework of the original contract signed in 2011. Services include engineering, procurement and construction management services associated with Saudi Aramco’s capital program. The services are being led by the Jacobs ZATE operation in Al-Khobar, Saudi Arabia.
The contract extension aligns with Saudi Aramco’s In-Kingdom Total Value Add program, which is designed to drive additional domestic value creation for Saudi Arabia through local employment, innovation, skills development and improved global competitiveness.
In making the announcement, Jacobs Senior Vice President Oil & Gas Bassim Shebaro stated, “We’re delighted by the opportunity to continue our close relationship with Saudi Aramco through this GES contract extension, and in doing so support local industry.
“We are proud of the Jacobs ZATE operation. We’ve made a strong commitment to this country and look forward to working closely with our clients and partners, including Saudi Aramco, to contribute to Saudi Arabia’s Vision 2030.”
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UDR, Inc. (UDR) Appoints New CFO
- NanoString (NSTG) Reports Presentation of Multiple Prosigna/PAM50 and Immuno-Oncology Studies at Breast Cancer Symposium
- Seattle Genetics (SGEN) Offers LT Follow-up Data on ADCETRIS in T-Cell Lymphomas; Median CR Duration Not Reached
Create E-mail Alert Related CategoriesCorporate News, Management Comments
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!